Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study

Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study

<b>Background.</b> This study aims to determine whether the administration of ferric carboxymaltose (FCM) in patients with acute heart failure (AHF) and iron deficiency (ID) improves morbidity and mortality. <b>Methods.</b> We studied 890 consecutive patients admitted for AHF...

Full description

Bibliographic Details
Main Authors: Raquel López-Vilella, Víctor Donoso Trenado, Pablo Jover Pastor, Ignacio Sánchez-Lázaro, Luis Martínez Dolz, Luis Almenar Bonet
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Life
Subjects:
acute heart failure
iron deficiency
ferric carboxymaltose
preserved ejection fraction
reduced ejection fraction
morbidity
Online Access:https://www.mdpi.com/2075-1729/12/11/1828

Internet

https://www.mdpi.com/2075-1729/12/11/1828

Similar Items